Enfermedad de Alzheimer
Alzheimer's disease is an unavoidable neurological disorder in which the death of brain cells causes memory loss and cognitive impairment that leads to dementia, being the most common cause of dementia in the elderly. Generally, it devel-ops in people over 65 years of age, increasing its incide...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
2022
|
| Subjects: | |
| Online Access: | https://dialnet.unirioja.es/servlet/oaiart?codigo=8603940 |
| Source: | RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 4, 2022, pags. 68-76 |
| Tags: |
Add Tag
No Tags: Be the first to tag this record
|
| id |
dialnet-ar-18-ART0001549014
|
|---|---|
| record_format |
dialnet
|
| institution |
Dialnet
|
| collection |
Dialnet AR
|
| source |
RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 4, 2022, pags. 68-76
|
| language |
Spanish
|
| topic |
Enfermedad de Alzheimer
Demencia Colinesterasa y Neurodegenerativas Alzheimer's Disease Dementia Cholinesterase and Neurodegenerative |
| spellingShingle |
Enfermedad de Alzheimer
Demencia Colinesterasa y Neurodegenerativas Alzheimer's Disease Dementia Cholinesterase and Neurodegenerative Toro Paca, María José Parra Parra, Diana Rebeca Pacheco Mena, Nathali Viviana Alvarado Galarza, Amanda Graciela Enfermedad de Alzheimer |
| description |
Alzheimer's disease is an unavoidable neurological disorder in which the death of brain cells causes memory loss and cognitive impairment that leads to dementia, being the most common cause of dementia in the elderly. Generally, it devel-ops in people over 65 years of age, increasing its incidence in those patients of even older age. It is considered one of the leading causes of death worldwide. Alzheimer's causes shrinkage of the brain due to the progressive loss of nerve cells and connections. Today, there is no known cure for this disease, because the death of brain cells in dementia cannot be stopped or reversed. There are also no modifying drugs available for Alzheimer's, however, some options may reduce your symptoms and help improve quality of life and therefore help patients to some extent. In this sense, through the following bibliographic review, it is sought to publicize the necessary measures to help patients suffering from this disease, addition-ally it seeks to expand support to people and caregivers to optimize awareness and commitment that improve quality and effectiveness of care.
|
| format |
Article
|
| author |
Toro Paca, María José
Parra Parra, Diana Rebeca Pacheco Mena, Nathali Viviana Alvarado Galarza, Amanda Graciela |
| author_facet |
Toro Paca, María José
Parra Parra, Diana Rebeca Pacheco Mena, Nathali Viviana Alvarado Galarza, Amanda Graciela |
| author_sort |
Toro Paca, María José
|
| title |
Enfermedad de Alzheimer
|
| title_short |
Enfermedad de Alzheimer
|
| title_full |
Enfermedad de Alzheimer
|
| title_fullStr |
Enfermedad de Alzheimer
|
| title_full_unstemmed |
Enfermedad de Alzheimer
|
| title_sort |
enfermedad de alzheimer
|
| publishDate |
2022
|
| url |
https://dialnet.unirioja.es/servlet/oaiart?codigo=8603940
|
| _version_ |
1767464035256631296
|
| spelling |
dialnet-ar-18-ART00015490142023-05-30Enfermedad de AlzheimerToro Paca, María JoséParra Parra, Diana RebecaPacheco Mena, Nathali VivianaAlvarado Galarza, Amanda GracielaEnfermedad de AlzheimerDemenciaColinesterasa y NeurodegenerativasAlzheimer's DiseaseDementiaCholinesterase and NeurodegenerativeAlzheimer's disease is an unavoidable neurological disorder in which the death of brain cells causes memory loss and cognitive impairment that leads to dementia, being the most common cause of dementia in the elderly. Generally, it devel-ops in people over 65 years of age, increasing its incidence in those patients of even older age. It is considered one of the leading causes of death worldwide. Alzheimer's causes shrinkage of the brain due to the progressive loss of nerve cells and connections. Today, there is no known cure for this disease, because the death of brain cells in dementia cannot be stopped or reversed. There are also no modifying drugs available for Alzheimer's, however, some options may reduce your symptoms and help improve quality of life and therefore help patients to some extent. In this sense, through the following bibliographic review, it is sought to publicize the necessary measures to help patients suffering from this disease, addition-ally it seeks to expand support to people and caregivers to optimize awareness and commitment that improve quality and effectiveness of care.La enfermedad de Alzheimer es un trastorno neurológico inevitable en el que la muerte de las células cerebrales provocan pérdida de memoria y deterioro cognitivo que desencadena en demencia, siendo la causa más común de demencia en ancianos. Generalmente, se desarrolla en personas mayores de 65 años incrementando su incidencia en aquellos pacientes de edad aún más avanzada. Se considera una de las principales causas de muerte a nivel mundial. El alzheimer produce la reducción del cerebro debido a la progresiva pérdida de células nerviosas y conexiones. Hoy en día, no existe una cura conocida para esta enfermedad, debido a que la muerte de las células cerebrales en la demencia no se pueden detener ni revertir. Tampoco se tienen medicamentos modificadores disponibles para el Alzheimer, sin embargo, algunas opciones pueden reducir sus síntomas y ayudar a mejorar la calidad de vida y, por lo tanto, ayudar a los pacientes hasta cierto punto. En tal sentido, por medio de la siguiente revisión bibliográfica, se busca dar a conocer las medidas necesarias para ayudar a los pacientes que padecen de esta enfermedad, adicionalmente se busca ampliar el apoyo a personas y cuidadores para optimar la conciencia y el compromiso que mejoren la calidad y la eficacia en la atención.2022text (article)application/pdfhttps://dialnet.unirioja.es/servlet/oaiart?codigo=8603940(Revista) ISSN 2588-073XRECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 4, 2022, pags. 68-76spaLICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI
|